Pfizer’s ABRYSVO Shows Promise as RSV Vaccine for At-Risk Adults: Phase 3 Study Results Pfizer’s announcement of positive trial results for its RSV vaccine, Abrysvo, in high-risk adults under... bigbreakingwire Apr 9, 2024 No Comments
bigbreakingwire